Treatment of persistent patent ductus arteriosus in preterm infants: Time to accept the null hypothesis

Journal of Perinatology

Volumn 30, Issue 4, 2010, Pages 241-252

  Benitz, W E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical practice; Ibuprofen; Indomethacin; Ligation; Patent ductus arteriosus; Preterm infant

Indexed keywords

DIURETIC AGENT; IBUPROFEN; INDOMETACIN;

ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHRONIC LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DUCTUS ARTERIOSUS OBLITERATION; EARLY INTERVENTION; ENCEPHALOMALACIA; EVIDENCE BASED MEDICINE; EXTREMELY LOW BIRTH WEIGHT; HUMAN; IMMATURITY; INFANT; INFANT MORTALITY; INTESTINE PERFORATION; LUNG DYSPLASIA; LUNG FUNCTION; LUNG HEMORRHAGE; NECROTIZING ENTEROCOLITIS; NULL HYPOTHESIS; PALLIATIVE THERAPY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; REVIEW; RISK BENEFIT ANALYSIS; SEPSIS; SYSTEMATIC REVIEW; THERAPY DELAY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIAC SURGICAL PROCEDURES; CONFIDENCE INTERVALS; DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LIGATION; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TREATMENT OUTCOME;

EID: 77950518104     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.3     Document Type: Review

References (138)

1. Burnard ED. The cardiac murmur in relation to symptoms in the newborn. Br Med J 1959; 1: 134-138.
2. Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-368.
3. Siassi B, Emmanouilides GC, Cleveland RJ, Hirose F. Patent ductus arteriosus complicating prolonged assisted ventilation in respiratory distress syndrome. J Pediatr 1969; 74: 11-19.
4. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284: 1333-1340.
5. Kitterman JA, Edmunds Jr LH, Gregory GA, Heymann MA, Tooley WH, Rudolph AM. Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management. N Engl J Med 1972; 287: 473-477.
6. Finlay ER, Subhedar NV. Pulmonary haemorrhage in preterm infants. Eur J Pediatr 2000; 159: 870-871.
7. Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000; 137: 68-72. (Pubitemid 30470925)
8. Jones RW, Pickering D. Persistent ductus arteriosus complicating the respiratory distress syndrome. Arch Dis Child 1977; 52: 274-281. (Pubitemid 8080199)
9. Jacob J, Gluck L, DiSessa T, Edwards D, Kulovich M, Kurlinski J et al. The contribution of PDA in the neonate with severe RDS. J Pediatr 1980; 96: 79-87. (Pubitemid 10160177)
10. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999; 104: 1345-1350.
11. Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 2002; 52: 713-719. (Pubitemid 35286040)
12. Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 2005; 147: 786-790. (Pubitemid 41774834)
13. Ryder RW, Shelton JD, Guinan ME. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980; 112: 113-123.
14. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr 2005; 40: 184-188. (Pubitemid 40269740)
15. Vanpee M, Ergander U, Herin P, Aperia A. Renal function in sick, very low-birthweight infants. Acta Paediatr 1993; 82: 714-718. (Pubitemid 23233702)
16. Dykes FD, Lazzara A, Ahmann P, Blumenstein B, Schwartz J, Brann AW. Intraventricular hemorrhage: a prospective evaluation of etiopathogenesis. Pediatrics 1980; 66: 42-49. (Pubitemid 10033802)
17. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996; 75: F183-F186. (Pubitemid 126439147)
18. Shortland DB, Gibson NA, Levene MI, Archer LN, Evans DH, Shaw DE. Patent ductus arteriosus and cerebral circulation in preterm infants. Dev Med Child Neurol 1990; 32: 386-393.
19. Drougia A, Giapros V, Krallis N, Theocharis P, Nikaki A, Tzoufi M et al. Incidence and risk factors for cerebral palsy in infants with perinatal problems: a 15-year review. Early Hum Dev 2007; 83: 541-547. (Pubitemid 47411475)
20. Dudell GG, Gersony WM. Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 1984; 104: 915-920.
21. Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 1978; 92: 467-473. (Pubitemid 8296513)
22. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005; 90: F235-F239. (Pubitemid 40593453)
23. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123: e138-e144.
24. Edmunds Jr LH, Gregory GA, Heymann MA, Kitterman JA, Rudolph AM, Tooley WH. Surgical closure of the ductus arteriosus in premature infants. Circulation 1973; 48: 856-863.
25. Gupta JM, Van Vliet PK, Fisk GC, Wright JS. Ductus ligation in respiratory distress syndrome. J Thorac Cardiovasc Surg 1972; 63: 642-647.
26. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 1976; 295: 526-529.
27. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530-533.
28. Kitterman JA. Patent ductus arteriosus: current clinical status. Arch Dis Child 1980; 55: 106-109. (Pubitemid 10133701)
29. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983; 102: 895-906. (Pubitemid 13058794)
30. Peckham GJ, Miettinen OS, Ellison RC, Kraybill EN, Gersony WM, Zierler S et al. Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. J Pediatr 1984; 105: 285-291.
31. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001; 6: 63-73.
32. Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007; 92: F498-F502.
33. Van Overmeire B. Patent ductus arteriosus: how aggressive should we be? Neonatology 2007; 91: 318.
34. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007; 150: 229-234, 234 e221. (Pubitemid 46343549)
35. Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007; 119: 1165-1174. (Pubitemid 46871273)
36. Clyman R, Cassady G, Kirklin JK, Collins M, Philips III JB. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 2009; 154: 873-876.
37. Hammerman C, Aramburo MJ. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr 1990; 117: 771-776. (Pubitemid 20382616)
38. Lee J, Rajadurai VS, Tan KW, Wong KY, Wong EH, Leong JY. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics 2003; 112: 345-350. (Pubitemid 36951397)
39. Rennie JM, Cooke RW. Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child 1991; 66: 55-58.
40. Rhodes PG, Ferguson MG, Reddy NS, Joransen JA, Gibson J. Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus. Eur J Pediatr 1988; 147: 481-484.
41. Tammela O, Ojala R, Iivainen T, Lautamatti V, Pokela ML, Janas M et al. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. J Pediatr 1999; 134: 552-557. (Pubitemid 30180592)
42. Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A. Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants. Med Wieku Rozwoj 2005; 9: 335-354.
43. Akisu M, Ozyurek AR, Dorak C, Parlar A, Kultursay N. Enteral ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm newborn infants [Premature bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazinin etkinligi ve guvenilirligi]. Cocuk Sagligi ve Hastaliklari Dergisi 2001; 44: 56-60.
44. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. Am J Perinatol 2007; 24: 267-270. (Pubitemid 46878753)
45. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003; 86(Suppl 3): S563-S569. (Pubitemid 38009742)
46. Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi 2007; 9: 399-403. (Pubitemid 47611418)
47. Gimeno Navarro A, Cano Sanchez A, Fernandez Gilino C, Carrasco Moreno J, Izquierdo Macian I, Gutierrez Laso A et al. Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants [Ibuprofeno frente a indometacina en el tratamiento del conducto arterioso persistente del prematuro]. Anales de Pediatria 2005; 63: 212-218.
48. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 2002; 161: 202-207. (Pubitemid 34253337)
49. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549-554. (Pubitemid 28006927)
50. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995; 346: 255.
51. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000; 47: 36-42. (Pubitemid 30038889)
52. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999; 135: 733-738. (Pubitemid 30180423)
53. Plavka R, Svihovek P, Borek I, Biolek J, Kostirova M, Liska K et al. Ibuprofen vs. indomethacin in the treatment of patent ductus arteriosus (PDA) in very premature neonates. Pediatr Res 2001; 49: 375A.
54. Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC. Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008; 93: F94-F99.
55. Su PH, Chen JY, Su CM, Huang TC, Lee HS. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int 2003; 45: 665-670. (Pubitemid 38130358)
56. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai 2002; 85(Suppl 4): S1252-S1258. (Pubitemid 36255069)
57. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997; 76: F179-F184. (Pubitemid 27319247)
58. Van Overmeire B, Follens I, Hatrtmann S, Mahieu L, Van Reempts PJ. Intravenous ibuprofen (IBU) for the treatment of patent ductus arterosius (PDA) in patients with respiratory distress syndrome (RDS). Pediatr Res 1996; 39: 250A.
59. Van Overmeire B, Langhendries JP, Van Haesebrouck P, Lecoutere D, Van de Broek H. Ibuprofen for early treatment of patent ductus arterosius, a randomized multicentre trial. Pediatr Res 1998; 43: 200A.
60. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674-681.
61. Osborn DA, Evans N, Kluckow M. Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2003; 88: F477-F482. (Pubitemid 37449421)
62. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978; 93: 647-651. (Pubitemid 8296513)
63. Levitsky S, Fisher E, Vidyasagar D, Hastreiter AR, Bennett E, Raju TN et al. Interruption of patent ductus arteriosus in premature infants with respiratory distress syndrome. Ann Thorac Surg 1976; 22: 131-137.
64. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989; 320: 1511-1516. (Pubitemid 19145802)
65. Nestrud RM, Hill DE, Arrington RW, Beard AG, Dungan WT, Lau PY et al. Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels. Dev Pharmacol Ther 1980; 1: 125-136. (Pubitemid 10149571)
66. Valaes T, Moylan FMB, Cohn H, Chung K, Nagpaul K, Chrenoff HI et al. Incidence and significance of PDA in preterm infants (PTI) and controlled trial of indomethacin. Pediatr Res 1980; 14: 452. (Pubitemid 10065944)
67. Neu J, Ariagno RL, Johnson JD, Pitlick PT, Cohen RS, Beets CL et al. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management. Pediatr Pharmacol (New York) 1981; 1: 245-249. (Pubitemid 11043749)
68. Yanagi RM, Wilson A, Newfeld EA, Aziz KU, Hunt CE. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Pediatrics 1981; 67: 647-652. (Pubitemid 11061284)
69. Mullett MD, Croghan TW, Myerberg DZ, Krall JM, Neal WA. Indomethacin for closure of patent ductus arteriosus in prematures. Clin Pediatr (Phila) 1982; 21: 217-220. (Pubitemid 12147920)
70. Kaapa P, Lanning P, Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 1983; 72: 179-184. (Pubitemid 13147534)
71. Rudd P, Montanez P, Hallidie-Smith K, Silverman M. Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Arch Dis Child 1983; 58: 267-270. (Pubitemid 13089462)
72. Vogtmann C, Grubbe G, Ruckhaberle KE, Bottcher H, Ockert C. Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants. Monatsschr Kinderheilkd 1988; 136: 636-639.
73. Lai TH, Soong WJ, Hwang B. Indomethacin for the prevention of symptomatic patent ductus arteriosus in very low birth weight infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1990; 31: 17-23.
74. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 1982; 306: 506-510. (Pubitemid 12175742)
75. Hammerman C, Strates E, Valaitis S. The silent ductus: its precursors and its aftermath. Pediatr Cardiol 1986; 7: 121-127. (Pubitemid 17225373)
76. Weesner KM, Dillard RG, Boyle RJ, Block SM. Prophylactic treatment of asymptomatic patent ductus arteriosus in premature infants with respiratory distress syndrome. South Med J 1987; 80: 706-708. (Pubitemid 18010701)
77. Cotton RB, Hickey DE, Graham TP, Stahlman MT. Effect of early indomethacin on ventilatory status of preterm infants with symptomatic patent ductus arteriosus [abstract]. Pediatr Res 1980; 14: 442.
78. Merritt TA, Harris JP, Roghmann K, Wood B, Campanella V, Alexson C et al. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. J Pediatr 1981; 99: 281-286. (Pubitemid 11046511)
79. Yeh TF, Goldbarg HR, Henek T, Thalji A, Pildes RS. Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and oneyear follow-up. Am J Dis Child 1982; 136: 803-807. (Pubitemid 12056176)
80. Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosusFa double-blind controlled study. J Pediatr 1981; 98: 137-145. (Pubitemid 11184081)
81. Monset-Couchard M, Dias-Mancano D, Murat I, Relier JP. Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants. Pediatrie 1983; 38: 365-377. (Pubitemid 14179285)
82. Krauss AN, Fatica N, Lewis BS, Cooper R, Thaler HT, Cirrincione C et al. Pulmonary function in preterm infants following treatment with intravenous indomethacin. Am J Dis Child 1989; 143: 78-81. (Pubitemid 19027271)
83. Van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001; 138: 205-211. (Pubitemid 32156435)
84. Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 2005; 115: 1529-1535. (Pubitemid 43843160)
85. Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr 2000; 89: 1369-1374.
86. De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Papacci P et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 2000; 159: 364-368. (Pubitemid 30243641)
87. Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1939-1944. (Pubitemid 39574596)
88. Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwe W, Jespers A et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, doubleblind, placebo-controlled trial. Lancet 2004; 364: 1945-1949. (Pubitemid 39574597)
89. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009; 26: 235-245.
90. Mahony L, Caldwell RL, Girod DA, Hurwitz RA, Jansen RD, Lemons JA et al. Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr 1985; 106: 801-805. (Pubitemid 15091051)
91. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Pitt BR, Taylor KJ et al. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr 1985; 107: 937-943. (Pubitemid 16197108)
92. Puckett CG, Cox MA, Haskins KS, Fisher DJ. Prophylactic indomethacin for the prevention of patent ductus arteriosus. Pediatr Res 1985; 19: 358.
93. Rennie JM, Doyle J, Cooke RW. Early administration of indomethacin to preterm infants. Arch Dis Child 1986; 61: 233-238. (Pubitemid 16108939)
94. Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr 1987; 111: 749-754. (Pubitemid 18017910)
95. Vincer M, Allen A, Evans J, Nwaesei C, Stinson D, Rees E et al. Early intravenous indomethacin prolongs respiratory support in very low birth weight infants. Acta Paediatr Scand 1987; 76: 894-897. (Pubitemid 18059853)
96. Bandstra ES, Montalvo BM, Goldberg RN, Pacheco I, Ferrer PL, Flynn J et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 1988; 82: 533-542.
97. Hanigan WC, Kennedy G, Roemisch F, Anderson R, Cusack T, Powers W. Administration of indomethacin for the prevention of periventricular- intraventricular hemorrhage in high-risk neonates. J Pediatr 1988; 112: 941-947.
98. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Taylor KJ, Scott DT et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr 1988; 112: 948-955.
99. Bada HS, Green RS, Pourcyrous M, Leffler CW, Korones SB, Magill HL et al. Indomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr 1989; 115: 631-637. (Pubitemid 19248849)
100. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994; 93: 543-550. (Pubitemid 24106595)
101. Ment LR, Oh W, Ehrenkranz RA, Phillip AG, Vohr B, Allan W et al. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr 1994; 124: 951-955. (Pubitemid 24184027)
102. Domanico RS, Waldman JD, Lester LA, McPhillips HA, Catrambone JE, Covert RF. Prophylactic indomethacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant-treaed infants
103. Couser RJ, Ferrara TB, Wright GB, Cabalka AK, Schilling CG, Hoekstra RE et al. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. J Pediatr 1996; 128: 631-637.
104. Yaseen H, al Umran K, Ali H, Rustum M, Darwich M, al-Faraidy A. Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. J Trop Pediatr 1997; 43: 42-46. (Pubitemid 27105690)
105. Supapannachart S, Khowsathit P, Patchakapati B. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams. J Med Assoc Thai 1999; 82(Suppl 1): S87-S92.
106. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966-1972. (Pubitemid 32568150)
107. Kumar Nair PA, Pai MG, Gazal HA, Da Costa DE, Al Khusaiby SM. Indomethacin prophylaxis for intraventricular hemorrhage in very low birth weight babies. Indian Pediatr 2004; 41: 551-558.
108. Gutierrez NG, Lapasset M. Prophylactic indomethacin and the incidence of patent ductus arteriosus in preterm neonates. Proc 3rd Argentinian Congr Perinatol 1987; 62 (as quoted in reference 113).
109. Morales-Suarez M, Danchez-Gil T, Lemus-Varela L, Udaeta-Mora E. Estudio comparitivo de dosis baja de indometicina profilactica para hemorragia subependimaria/intraventicular en neonatos pretermino con ventilation mechanica. Bol Med Hosp Infant Mex 1994; 51: 389-394. (Pubitemid 24239898)
110. Alfaleh K, Smyth JA, Roberts RS, Solimano A, Asztalos EV, Schmidt B. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics 2008; 121: e233-e238. (Pubitemid 351198427)
111. Couser RJ, Hoekstra RE, Ferrara TB, Wright GB, Cabalka AK, Connett JE. Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin. Arch Pediatr Adolesc Med 2000; 154: 598-602.
112. Ment LR, Vohr B, Allan W, Westerveld M, Sparrow SS, Schneider KC et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2000; 105: 485-491. (Pubitemid 30129659)
113. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002; CD000174.
114. Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003; CD003745.
115. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; CD004213. (Pubitemid 351824590)
116. Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2008; CD003951. (Pubitemid 351807685)
117. Mosalli R, Alfaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev 2008; CD006181.
118. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2008; CD003481.
119. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd edn. Blackwell Science: London, 1994.
120. Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 1996; 128: 601-607.
121. Clyman RI, Chorne N. Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007; 150: 216-219. (Pubitemid 46328984)
122. Bose CL, Laughon M. Treatment to prevent patency of the ductus arteriosus: beneficial or harmful? J Pediatr 2006; 148: 713-714. (Pubitemid 43849826)
123. Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 2006; 148: 730-734. (Pubitemid 43870093)
124. Powell ML. Patent ductus arteriosus in premature infants. Med J Aust 1963; 2: 58-60.
125. Auld PA. Delayed closure of the ductus arteriosus. J Pediatr 1966; 69: 61-66.
126. Danilowicz D, Rudolph AM, Hoffman JI. Delayed closure of the ductus arteriosus in premature infants. Pediatrics 1966; 37: 74-78.
127. Hallidie-Smith KA. Murmur of persistent ductus arteriosus in premature infants. Arch Dis Child 1972; 47: 725-730.
128. Clarkson PM, Orgill AA. Continuous murmurs in infants of low birth weight. J Pediatr 1974; 84: 208-211.
129. Siassi B, Blanco C, Cabal LA, Coran AG. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants. Pediatrics 1976; 57: 347-351.
130. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117: 1113-1121.
131. Dani C, Bertini G, Corsini I, Elia S, Vangi V, Pratesi S et al. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance. Acta Paediatr 2008; 97: 1176-1180.
132. Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM. The ductus arteriosus rarely requires treatment in infants >1000 grams. Am J Perinatol 2008; 25: 661-666.
133. Herrman K, Bose C, Lewis K, Laughon M. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 2009; 94: F48-F50.
134. Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996; 128: 470-478. (Pubitemid 26114083)
135. Adzick NS, Harrison MR, deLorimier AA. Surgical clip ligation of patent ductus arteriosus in premature infants. J Pediatr Surg 1986; 21: 158.
136. McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007; 92: F424-F427. (Pubitemid 350043994)
137. Nelson DP, Schwartz SM, Chang AC. Neonatal physiology of the functionally univentricular heart. Cardiol Young 2004; 14(Suppl 1): 52-60.
138. Lister G, Hellenbrand WE, Kleinman CS, Talner NS. Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects. N Engl J Med 1982; 306: 502-506. (Pubitemid 12175741)